Bisphenol a in chronic kidney disease

International Journal of Nephrology

Volumn 2013, Issue , 2013, Pages

  González Parra, Emilio ^a,b   Herrero, Jose Antonio ^c   Elewa, Usama ^a   Bosch, Ricardo J ^d   Arduán, Alberto Ortiz ^a,b   Egido, Jesus ^a,b,e  

^a UAM)   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884262790     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2013/437857     Document Type: Review

References (78)

1. Bailey J. M., Mitch W. E., Pathophysiology of uremia. Brenner and Rector. The Kidney 2000 6th W. B. Saunders Company 2059 2078
2. Vanholder R., Baurmeister U., Brunet P., Cohen G., Glorieux G., Jankowski J., A bench to bedside view of uremic toxins. Journal of the American Society of Nephrology 2008 19 5 863 870 2-s2.0-44049106323 10.1681/ASN.2007121377
3. Rhee E. P., Souza A., Farrell L., Pollak M. R., Lewis G. D., Steele D. J. R., Thadhani R., Clish C. B., Greka A., Gerszten R. E., Metabolite profiling identifies markers of uremia. Journal of the American Society of Nephrology 2010 21 6 1041 1051 2-s2.0-77952979558 10.1681/ASN.2009111132
4. Wikoff W. R., Anfora A. T., Liu J., Schultz P. G., Lesley S. A., Peters E. C., Siuzdak G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 2009 106 10 3698 3703 2-s2.0-62649151803 10.1073/pnas.0812874106
5. Goldfarb D. S., Modersitzki F., Asplin J. R., A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clinical Journal of the American Society of Nephrology 2007 2 4 745 749 2-s2.0-34548824862 10.2215/CJN.00600207
6. Bammens B., Evenepoel P., Verbeke K., Vanrenterghem Y., Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. American Journal of Kidney Diseases 2004 44 2 278 285 2-s2.0-3242684582 10.1053/j.ajkd.2004.04.033
7. Testa A., Dejoie T., Lecarrer D., Wratten M., Sereni L., Renaux J. L., Reduction of free immunoglobulin light chains using adsorption properties of hemodiafiltration with endogenous reinfusion. Blood Purification 2010 30 1 34 36 2-s2.0-77953927883 10.1159/000316684
8. Evenepoel P., Meijers B. K. I., Bammens B. R. M., Verbeke K., Uremic toxins originating from colonic microbial metabolism. Kidney International. Supplement 2009 114 S12 S19 2-s2.0-77449086072
9. Jourde-Chiche N., Dou L., Cerini C., Dignat-George F., Vanholder R., Brunet P., Protein-bound toxins-update 2009. Seminars in Dialysis 2009 22 4 334 339 2-s2.0-69249098848 10.1111/j.1525-139X.2009.00576.x
10. Martinez A. W., Recht N. S., Hostetter T. H., Meyer T. W., Removal of P-cresol sulfate by hemodialysis. Journal of the American Society of Nephrology 2005 16 11 3430 3436 2-s2.0-33644874985 10.1681/ASN.2005030310
11. Meijers B. K. I., Bammens B., De Moor B., Verbeke K., Vanrenterghem Y., Evenepoel P., Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney International 2008 73 10 1174 1180 2-s2.0-42949119698 10.1038/ki.2008.31
12. Schmidt S., Westhoff T. H., Krauser P., Ignatius R., Jankowski J., Jankowski V., Zidek W., Van Der Giet M., The uraemic toxin phenylacetic acid impairs macrophage function. Nephrology Dialysis Transplantation 2008 23 11 3485 3493 2-s2.0-54149094147 10.1093/ndt/gfn266
13. Schmidt S., Westhoff T. H., Krauser P., Zidek W., Van Der Giet M., The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells. Nephrology Dialysis Transplantation 2008 23 1 65 71 2-s2.0-44449172707 10.1093/ndt/gfm475
14. Yano S., Yamaguchi T., Kanazawa I., Ogawa N., Hayashi K., Yamauchi M., Sugimoto T., The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure. Nephrology Dialysis Transplantation 2007 22 11 3160 3165 2-s2.0-36749037260 10.1093/ndt/gfm455
15. Yoshida K., Yoneda T., Kimura S., Fujimoto K., Okajima E., Hirao Y., Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay. Therapeutic Apheresis and Dialysis 2006 10 3 267 272 2-s2.0-33745529328 10.1111/j.1744-9987.2006.00370.x
16. Galli F., Beninati S., Benedetti S., Lentini A., Canestrari F., Tabilio A., Buoncristiani U., Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis. Kidney International, Supplement 2001 59 78 S73 S76 2-s2.0-0035122184
17. Raff A. C., Meyer T. W., Hostetter T. H., New insights into uremic toxicity. Current Opinion in Nephrology and Hypertension 2008 17 6 560 565 2-s2.0-56249108096 10.1097/MNH.0b013e32830f45b6
18. Faure V., Dou L., Sabatier F., Cerini C., Sampol J., Berland Y., Brunet P., Dignat-George F., Elevation of circulating endothelial microparticles in patients with chronic renal failure. Journal of Thrombosis and Haemostasis 2006 4 3 566 573 2-s2.0-33645965258 10.1111/j.1538-7836.2005.01780.x
19. Motojima M., Hosokawa A., Yamato H., Muraki T., Yoshioka T., Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF- B and free radical in proximal tubular cells. Kidney International 2003 63 5 1671 1680 2-s2.0-0242669257 10.1046/j.1523-1755.2003.00906.x
20. Satoh M., Hayashi H., Watanabe M., Ueda K., Yamato H., Yoshioka T., Motojima M., Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Experimental Nephrology 2003 95 3 e111 e118
21. Meijers B. K. I., Evenepoel P., The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrology Dialysis Transplantation 2011 26 3 759 761 2-s2.0-79952154288 10.1093/ndt/gfq818
22. Wu I.-W., Hsu K.-H., Lee C.-C., Sun C.-Y., Hsu H.-J., Tsai C.-J., Tzen C.-Y., Wang Y.-C., Lin C.-Y., Wu M.-S., P-cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrology Dialysis Transplantation 2011 26 3 938 947 2-s2.0-79952174195 10.1093/ndt/gfq580
23. Barreto F. C., Barreto D. V., Liabeuf S., Meert N., Glorieux G., Temmar M., Choukroun G., Vanholder R., Massy Z. A., Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clinical Journal of the American Society of Nephrology 2009 4 10 1551 1558 2-s2.0-73349083067 10.2215/CJN.03980609
24. Yamamoto H., Tsuruoka S., Ioka T., Ando H., Ito C., Akimoto T., Fujimura A., Asano Y., Kusano E., Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney International 2006 69 10 1780 1785 2-s2.0-33646713442 10.1038/sj.ki.5000340
25. Lekawanvijit S., Adrahtas A., Kelly D. J., Kompa A. R., Wang B. H., Krum H., Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? European Heart Journal 2010 31 14 1771 1779 2-s2.0-77954786480 10.1093/eurheartj/ehp574
26. Chiang C.-K., Tanaka T., Inagi R., Fujita T., Nangaku M., Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Laboratory Investigation 2011 91 11 1564 1571 2-s2.0-80155151941 10.1038/labinvest.2011.114
27. Nii-Kono T., Iwasaki Y., Uchida M., Fujieda A., Hosokawa A., Motojima M., Yamato H., Kurokawa K., Fukagawa M., Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney International 2007 71 8 738 743 2-s2.0-34247219265 10.1038/sj.ki.5002097
28. Hida M., Aiba Y., Sawamura S., Suzuki N., Satoh T., Koga Y., Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oval administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996 74 2 349 355 2-s2.0-0029834566
29. Aguilera A., Bajo M. A., Espinoza M., Olveira A., Paiva A. M., Codoceo R., García P., Sánchez S., Celadilla O., Castro M. J., Selgas R., Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. American Journal of Kidney Diseases 2003 42 4 787 796 2-s2.0-10744220968 10.1016/S0272-6386(03)00920-X
30. De Preter V., Vanhoutte T., Huys G., Swings J., De Vuyst L., Rutgeerts P., Verbeke K., Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. American Journal of Physiology 2007 292 1 G358 G368 2-s2.0-33846156865 10.1152/ajpgi.00052.2006
31. Nakabayashi I., Nakamura M., Kawakami K., Ohta T., Kato I., Uchida K., Yoshida M., Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrology Dialysis Transplantation 2011 26 3 1094 1098 2-s2.0-79952176810 10.1093/ndt/gfq624
32. Evenepoel P., Bammens B., Verbeke K., Vanrenterghem Y., Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study. Kidney International 2006 70 1 192 198 2-s2.0-33745725902 10.1038/sj.ki.5001523
33. Evenepoel P., Meijers B. K., Dietary fiber and protein: nutritional therapy in chronic kidney disease and beyond. Kidney International 2012 81 3 227 229 2-s2.0-84856690404 10.1038/ki.2011.394
34. Niwa T., Ise M., Miyazaki T., Meada K., Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats. Nephron 1993 65 1 82 87 2-s2.0-0027249628
35. Shoji T., Wada A., Inoue K., Hayashi D., Tomida K., Furumatsu Y., Kaneko T., Okada N., Fukuhara Y., Imai E., Tsubakihara Y., Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function. Nephron 2007 105 3 c99 c107 2-s2.0-33846794398 10.1159/000097985
36. Dodds E. C., Goldberg L., Lawson W., Robinson B., OEstrogenic activity of certain synthetic compounds. Nature 1938 141 3562 247 248 2-s2.0-33749017015
37. Casajuana N., Lacorte S., New methodology for the determination of phthalate esters, bisphenol A, bisphenol A diglycidyl ether, and nonylphenol in commercial whole milk samples. Journal of Agricultural and Food Chemistry 2004 52 12 3702 3707 2-s2.0-2942535954 10.1021/jf040027s
38. Thomson B. M., Grounds P. R., Bisphenol A in canned foods in New Zealand: an exposure assessment. Food Additives and Contaminants 2005 22 1 65 72 2-s2.0-14844364708 10.1080/02652030400027920
39. Vandenberg L. N., Chahoud I., Heindel J. J., Padmanabhan V., Paumgartten F. J. R., Schoenfelder G., Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environmental Health Perspectives 2010 118 8 1055 1070 2-s2.0-77955269249 10.1289/ehp.0901716
40. Dekant W., Völkel W., Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicology and Applied Pharmacology 2008 228 1 114 134 2-s2.0-40849137668 10.1016/j.taap.2007.12.008
41. Lemos M. F. L., Van Gestel C. A. M., Soares A. M. V. M., Developmental toxicity of endocrine disrupters bisphenol A and vinclozolin in a terrestrial isopod. Archives of Environmental Contamination and Toxicology 2010 59 2 274 281 2-s2.0-77955497471 10.1007/s00244-010-9474-9
42. Bindhumol V., Chitra K. C., Mathur P. P., Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 2003 188 2-3 117 124 2-s2.0-0038060724 10.1016/S0300-483X(03)00056-8
43. Ropero A. B., Alonso-Magdalena P., García-García E., Ripoll C., Fuentes E., Nadal A., Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. International Journal of Andrology 2008 31 2 194 199 2-s2.0-40349088795 10.1111/j.1365-2605.2007.00832.x
44. Richter C. A., Birnbaum L. S., Farabollini F., Newbold R. R., Rubin B. S., Talsness C. E., Vandenbergh J. G., Walser-Kuntz D. R., vom Saal F. S., In vivo effects of bisphenol A in laboratory rodent studies. Reproductive Toxicology 2007 24 2 199 224 2-s2.0-34548529042 10.1016/j.reprotox.2007.06.004
45. Vasiliu O., Cameron L., Gardiner J., DeGuire P., Karmaus W., Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 2006 17 4 352 359 2-s2.0-33746901469 10.1097/01.ede.0000220553.84350.c5
46. Braun J. M., Hauser R., Bisphenol A and children's health. Current Opinion in Pediatrics 2011 23 2 233 239 2-s2.0-79954425553 10.1097/MOP. 0b013e3283445675
47. Perera F., Vishnevetsky J., Herbstman J. B., Calafat A. M., Xiong W., Rauh V., Wang S., Prenatal bisphenol A exposure and child behavior in an inner-city cohort. Environmental Health Perspectives 2012 120 8 1190 1194
48. Wang T., Li M., Chen B., Xu M., Xu Y., Huang Y., Lu J., Chen Y., Wang W., Li X., Liu Y., Bi Y., Lai S., Ning G., Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2012 97 2 E223 E227 2-s2.0-84856764834 10.1210/jc.2011-1989
49. Shankar A., Teppala S., Relationship between urinary bisphenol A levels and diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2011 96 12 3822 3826 2-s2.0-83155168483 10.1210/jc.2011-1682
50. Lind P. M., Lind L., Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly. Atherosclerosis 2011 218 1 207 213 2-s2.0-79959502634 10.1016/j.atherosclerosis.2011.05.001
51. FDA (Food and drug Administration) Draft assessment of bisphenol A for use in food contact applications, http://www.fda.gov/NewsEvents/ PublicHealthFocus/ucm064437.htm
52. Vandenberg L. N., Chahoud I., Padmanabhan V., Paumgartten F. J. R., Schoenfelder G., Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environmental Health Perspectives 2010 118 8 1051 1054 2-s2.0-77956068705 10.1289/ehp.0901717
53. Yang Y.-J., Lee S.-Y., Kim K.-Y., Hong Y.-P., Acute testis toxicity of bisphenol a diglycidyl ether in Sprague-Dawley rats. Journal of Preventive Medicine and Public Health 2010 43 2 131 137 2-s2.0-77953674459 10.3961/jpmph.2010.43.2.131
54. Kim M. E., Park H. R., Gong E. J., Choi S. Y., Kim H. S., Lee J., Exposure to bisphenol A appears to impair hippocampal neurogenesis and spatial learning and memory. Food and Chemical Toxicology 2011 49 12 3383 3389 2-s2.0-80054987714 10.1016/j.fct.2011.09.017
55. Gonçalves C. R., Cunha R. W., Barros D. M., Martínez P. E., Effects of prenatal and postnatal exposure to a low dose of bisphenol A on behavior and memory in rats. Environmental Toxicology and Pharmacology 2010 30 2 195 201
56. Xu X., Tian D., Hong X., Chen L., Xie L., Sex-specific influence of exposure to bisphenol-A between adolescence and young adulthood on mouse behaviors. Neuropharmacology 2011 61 4 565 573 2-s2.0-79959947000 10.1016/j.neuropharm.2011.04.027
57. Patisaul H. B., Polston E. K., Influence of endocrine active compounds on the developing rodent brain. Brain Research Reviews 2008 57 2 352 362 2-s2.0-40749155811 10.1016/j.brainresrev.2007.06.008
58. Rubin B. S., Soto A. M., Bisphenol A: perinatal exposure and body weight. Molecular and Cellular Endocrinology 2009 304 1-2 55 62 2-s2.0-67349209522 10.1016/j.mce.2009.02.023
59. Somm E., Schwitzgebel V. M., Toulotte A., Cederroth C. R., Combescure C., Nef S., Aubert M. L., Hüppi P. S., Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environmental Health Perspectives 2009 117 10 1549 1555 2-s2.0-70449558975 10.1289/ehp.11342
60. Nagel S. C., Vom Saal F. S., Thayer K. A., Dhar M. G., Boechler M., Welshons W. V., Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environmental Health Perspectives 1997 105 1 70 76 2-s2.0-0030893546
61. Timms B. G., Howdeshell K. L., Barton L., Bradley S., Richter C. A., Vom Saal F. S., Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proceedings of the National Academy of Sciences of the United States of America 2005 102 19 7014 7019 2-s2.0-18744399025 10.1073/pnas.0502544102
62. Prins G. S., Tang W.-Y., Belmonte J., Ho S.-M., Developmental exposure to bisphenol A increases prostate cancer susceptibility in adult rats: epigenetic mode of action is implicated. Fertility and Sterility 2008 89 2, supplement e41 2-s2.0-41749098872 10.1016/j.fertnstert.2007.12.023
63. Salian S., Doshi T., Vanage G., Perinatal exposure of rats to Bisphenol A affects fertility of male offspring-An overview. Reproductive Toxicology 2011 31 3 359 362 2-s2.0-79953760336 10.1016/j.reprotox.2010.10.008
64. Carwile J. L., Ye X., Zhou X., Calafat A. M., Michels K. B., Canned soup consumption and urinary bisphenol A: a randomized crossover trial. Journal of the American Medical Association 2011 306 20 2218 2220 2-s2.0-81855191350 10.1001/jama.2011.1721
65. Braun J. M., Yolton K., Dietrich K. N., Hornung R., Ye X., Calafat A. M., Lanphear B. P., Prenatal bisphenol A exposure and early childhood behavior. Environmental Health Perspectives 2009 117 12 1945 1952 2-s2.0-75349095250 10.1289/ehp.0900979
66. Melzer D., Osborne N. J., Henley W. E., Cipelli R., Young A., Money C., McCormack P., Luben R., Khaw K.-T., Wareham N. J., Galloway T. S., Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012 125 12 1482 1490 2-s2.0-84859107392 10.1161/CIRCULATIONAHA.111.069153
67. Shankar A., Teppala S., Urinary bisphenol A and hypertension in a multiethnic sample of US adults. Journal of Environmental and Public Health 2012 2012 5 2-s2.0-84858311151 10.1155/2012/481641 481641
68. Li M., Bi Y., Qi L., Wang T., Xu M., Huang Y., Xu Y., Chen Y., Lu J., Wang W., Ning G., Exposure to bisphenol A is associated with low-grade albuminuria in Chinese adults. Kidney International 2012 81 1131 1138 2-s2.0-84857714412 10.1038/ki.2012.6
69. Trasande L., Attina T. M., Trachtman H., Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney International 2013 83 4 741 748
70. You L., Zhu X., Shrubsole M. J., Fan H., Chen J., Dong J., Hao C.-M., Dai Q., Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environmental Health Perspectives 2011 119 4 527 533 2-s2.0-79955570430 10.1289/ehp.1002572
71. Murakami K., Ohashi A., Hori H., Hibiya M., Shoji Y., Kunisaki M., Akita M., Yagi A., Sugiyama K., Shimozato S., Ito K., Takahashi H., Takahashi K., Yamamoto K., Kasugai M., Kawamura N., Nakai S., Hasegawa M., Tomita M., Nabeshima K., Hiki Y., Sugiyama S., Accumulation of bisphenol A in hemodialysis patients. Blood Purification 2007 25 3 290 294 2-s2.0-34447519144 10.1159/000104869
72. Boeniger M. F., Lowry L. K., Rosenberg J., Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. American Industrial Hygiene Association Journal 1993 54 10 615 627 2-s2.0-0027496681
73. Haishima Y., Hayashi Y., Yagami T., Nakamura A., Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins. Journal of Biomedical Materials Research 2001 58 2 209 215
74. Shintani H., Determination of the endocrine disrupter bisphenol-A in the blood of uremia patients treated by dialysis. Chromatographia 2001 53 5-6 331 333 2-s2.0-0035084362
75. Yamasaki H., Nagake Y., Makino H., Determination of bisphenol A in effluents of hemodialyzers. Nephron 2001 88 4 376 378 2-s2.0-0034929188 10.1159/000046023
76. Krieter D. H., Canaud B., Lemke H. D., Rodriguez A., Morgenroth A., von Appen K., Dragoun G. P., Wanner C., Bisphenol A in chronic kidney disease. Artificial Organs 2013 37 3 283 290
77. Sugimura K., Naganuma T., Kakiya Y., Okada C., Sugimura T., Kishimoto T., Endocrine-disrupting chemicals in CAPD dialysate and effluent. Blood Purification 2001 19 1 21 23 2-s2.0-0035207624
78. Duranton F., Cohen G., De Smet R., Rodriguez M., Jankowski J., Vanholder R., Argiles A., Normal and pathologic concentrations of uremic toxins. Journal of the American Society of Nephrology 2012 23 7 1258 1270